Details

Ferrex 150 olysaccharide-Iron complex capsules are a product of ferric iron complexed to a low molecular weight polysaccharide. This polysaccharide is a product of extensive hydrolysis of starch. Ferrex 150 is a dark brown powder that forms a very dark brown solution when dissolved in water. It is tasteless and odorless. As an organic complex, it contains no free irons.

Ingredients

Other Ingredients: Sodium Lauryl Sulfate, Gelatin, Microcrystalline Cellulose, Stearic Acid, Polyethylene Glycol, Citric Acid, Croscarmellose Sodium, Titanium Dioxide, Polyvinylpyrrolidone, FD&C Yellow 5 Lake (Contains FD&C Yellow 5 Lake (Tartrazine) as a Color Additive), FD&C Red 40 Lake, FD&C Red 3 Lake and FD&C Blue 1 Lake.

Directions

Indications and Usage: Ferrex 150 may be used for the dietary management of iron deficiencies. Contraindications: Ferrex 150 is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications in the use of this dietary supplement. Dosage and Administration: Adults: One or two capsules daily, or as prescribed by a physician. How Supplied: Unit dose blister packs, 10 capsules per card, orange/brown capsules imprinted B203.

Store at 25 degrees C (77 degrees F); excursions permitted to 15 degrees -30 degrees C (59 degrees -86 degrees F). See USP controlled room temperature.

Warnings

Warning: Consuming this product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov/food., For dispensing purpose only. Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center (1-800-222-1222) immediately. Precaution: This product contains FD&C Yellow No. 5 Lake (tartrazine), which may cause allergic-type reactions (including bronchial asthma) in certain susceptible persons. Although the overall incidence of FD&C Yellow No. 5 Lake (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity. The type of anemia and the underlying cause or causes should be determined before initiating supplementation with Ferrex 150. Since the anemia may be a result of a systematic disturbance, such as a recurrent blood loss, the underlying cause or causes should be corrected if possible. Since oral iron products interfere with absorption of certain antibiotics, these products should not be taken within two hours of each other. Precautions (continued): As with all oral iron preparations, ferrextm 150 should be stored out of the reach of children to protect against accidental iron poisoning. Patients should not exceed the recommended dosage unless directed by a physician. Patients should be informed that iron products can cause dark or black stools. Adverse Reactions: Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stool and abdominal pain. Adverse reactions with iron therapy are usually transient. Overdose: The clinical cause of acute iron overdose can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma. Keep this and all medications out of the reach of children. Do not use if blister seals are broken.